During the past decade, Hospital General Nuestra Señora del Prado conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital General Nuestra Señora del Prado" #1 sponsor was "PETHEMA Foundation" with 8 trials, followed by "University of Castilla-La Mancha" with 4 trials sponsored, "Castilla-La Mancha Health Service" with 2 trials sponsored, "Grupo Español de Rehabilitación Multimodal" with 2 trials sponsored and "Asociación Española de Fabricantes y Distribuidores de Productos de Nutrición Enteral" with 2 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital General Nuestra Señora del Prado" #1 collaborator was "Dynamic Science S.L." with 3 trials as a collaborator, "Celgene" with 2 trials as a collaborator, "Millennium Pharmaceuticals, Inc." with 2 trials as a collaborator, "Asociación Científica Pulmón y Ventilación Mecánica" with 1 trials as a collaborator and "Castilla-La Mancha Health Service" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Hospital General Nuestra Señora del Prado" are "Multiple Myeloma" (4 trials), "Fibromyalgia" (3 trials), "Perioperative Care" (2 trials), "Postoperative Complications" (2 trials) and "Type 1 Diabetes" (2 trials). Many other conditions were trialed in "Hospital General Nuestra Señora del Prado" in a lesser frequency.

Most popular intervention types in "Hospital General Nuestra Señora del Prado" are "Drug" (10 trials), "Device" (7 trials), "Other" (3 trials), "Procedure" (3 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Cytarabine" (2 trials), "Dexamethasone" (2 trials), "Prednisone" (2 trials), "ATRA" (1 trials) and "Allogenic Transplantation" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital General Nuestra Señora del Prado" are 24 trials for "All" genders.

Currently, there are NaN active trials in "Hospital General Nuestra Señora del Prado". 1 are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in Hospital General Nuestra Señora del Prado, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital General Nuestra Señora del Prado, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 5 trials that are defined as “Not Applicable".